Osaic Holdings’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$109K Sell
423
-6,309
-94% -$1.68M ﹤0.01% 4615
2025
Q4
$1.66M Buy
6,732
+6,344
+1,635% +$1.34M ﹤0.01% 2241
2025
Q3
$61.9K Sell
388
-5
-1% -$748 ﹤0.01% 5172
2025
Q2
$54.3K Buy
393
+115
+41% +$16.9K ﹤0.01% 4986
2025
Q1
$50.1K Sell
278
-28
-9% -$4.71K ﹤0.01% 4714
2024
Q4
$47.9K Buy
306
+19
+7% +$3.37K ﹤0.01% 4734
2024
Q3
$52.2K Buy
287
+11
+4% +$2.12K ﹤0.01% 4717
2024
Q2
$50.7K Buy
276
+24
+10% +$4.03K ﹤0.01% 4665
2024
Q1
$44.8K Sell
252
-473
-65% -$65.7K ﹤0.01% 4826
2023
Q4
$89.9K Sell
725
-204
-22% -$22.6K ﹤0.01% 4507
2023
Q3
$108K Buy
929
+533
+135% +$65K ﹤0.01% 4450
2023
Q2
$46.5K Buy
396
+261
+193% +$26.6K ﹤0.01% 4987
2023
Q1
$10.8K Buy
135
+20
+17% +$1.57K ﹤0.01% 5933
2022
Q4
$9K Buy
115
+6
+6% +$445 ﹤0.01% 6000
2022
Q3
$8K Buy
109
+12
+12% +$867 ﹤0.01% 6130
2022
Q2
$6K Sell
97
-3
-3% -$187 ﹤0.01% 6386
2022
Q1
$7K Buy
100
+96
+2,400% +$5.99K ﹤0.01% 6329
2021
Q4
$0 Sell
4
-615
-99% -$35.8K ﹤0.01% 7486
2021
Q3
$32K Buy
+619
New +$36.6K ﹤0.01% 5442

Other funds holding KRYS